1. LncRNA CRNDE inhibits cardiomyocytes apoptosis by YAP1 in myocardial ischaemia/reperfusion injury
   Xiaohua Zhu et al, 2021, Autoimmunity CrossRef
2. Network regression analysis for binary and ordinal categorical phenotypes in transcriptome-wide association studies
   Liye Zhang et al, 2022, Genetics CrossRef
3. Identification of Dysregulated Mechanisms and Potential Biomarkers in Ischemic Stroke Onset
   Bing Feng et al, 2021, International Journal of General Medicine CrossRef
4. Circ-LTBP1 is involved in doxorubicin-induced intracellular toxicity in cardiomyocytes via miR-107/ADCY1 signal
   Chunxia Li et al, 2022, Molecular and Cellular Biochemistry CrossRef
5. Time-related accurate investigation of multicomponent drug interventions in heart failure
   Menglan Wang et al, 2022, Phytomedicine Plus CrossRef
6. Huoxin Pill inhibits isoproterenol-induced transdifferentiation and collagen synthesis in cardiac fibroblasts through the TGF-β/Smads pathway
   Meizhong Peng et al, 2021, Journal of Ethnopharmacology CrossRef
7. Cardiotoxicity of (−)‐borneol, (+)‐borneol, and isoborneol in zebrafish embryos is associated with Na+/K+‐ATPase and Ca2+‐ATPase inhibition
   Xuan Ni et al, 2023, Journal of Applied Toxicology CrossRef
8. Suxiao Jiuxin Pill attenuates acute myocardial ischemia via regulation of coronary artery tone
   Sa Li et al, 2023, Frontiers in Pharmacology CrossRef
9. Recent advances of traditional chinese medicine in the regulation of myocardial mitochondrial function
   Fang Li et al, 2022, World Journal of Traditional Chinese Medicine CrossRef
10. The flavonoid baicalin improves glucose metabolism by targeting the PH domain of AKT and activating AKT/GSK3β phosphorylation
    Shengnan Yang et al, 2019, FEBS Letters CrossRef
11. Efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina (Qi stagnation and blood stasis syndrome): study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial
    Xiaofen Ruan et al, 2021, Trials CrossRef
12. Serum proteomic analysis reveals the cardioprotective effects of Shexiang Baoxin Pill and Suxiao Jiuxin Pill in a rat model of acute myocardial infarction
    Nixue Song et al, 2022, Journal of Ethnopharmacology CrossRef
13. Evaluation of the efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina: A randomized, double-blind, placebo-controlled, multi-center clinical trial
    Yuan-long Sun et al, 2024, Journal of Ethnopharmacology CrossRef
14. Implication of RAS in Postnatal Cardiac Remodeling, Fibrosis and Dysfunction Induced by Fetal Undernutrition
    Pilar Rodríguez-Rodríguez et al, 2021, Pathophysiology CrossRef
15. The Therapeutic Effects of Ligustrazine in Combination with Other Drugs in Cardiovascular Diseases
    Peihua Dong et al, 2023, International Journal of Drug Discovery and Pharmacology CrossRef
16. Microbiome-metabolome reveals that the Suxiao Jiuxin pill attenuates acute myocardial infarction associated with fatty acid metabolism
    Jingyu Liao et al, 2023, Journal of Ethnopharmacology CrossRef
17. Effects of the Suxiao Jiuxin pill on acute myocardial infarction assessed by comprehensive metabolomics
    Gaosong Wu et al, 2020, Phytomedicine CrossRef
18. Anti-apoptotic effect of Suxiao Jiuxin Pills against hypoxia-induced injury through PI3K/Akt/GSK3β pathway in HL-1 cardiomyocytes
    Yiping Li et al, 2018, Journal of the Chinese Medical Association CrossRef